McKelvy J - Search Results

1

Evaluation of ITX 5061, a scavenger receptor B1 antagonist: resistance selection and activity in combination with other hepatitis C virus antivirals.

Zhu H, Wong-Staal F, Lee H, Syder A, McKelvy J, Schooley RT, Wyles DL. Zhu H, et al. Among authors: mckelvy j. J Infect Dis. 2012 Feb 15;205(4):656-62. doi: 10.1093/infdis/jir802. J Infect Dis. 2012. PMID: 22279172 Free PMC article.

2

Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.

Syder AJ, Lee H, Zeisel MB, Grove J, Soulier E, Macdonald J, Chow S, Chang J, Baumert TF, McKeating JA, McKelvy J, Wong-Staal F. Syder AJ, et al. Among authors: mckelvy j. J Hepatol. 2011 Jan;54(1):48-55. doi: 10.1016/j.jhep.2010.06.024. Epub 2010 Aug 21. J Hepatol. 2011. PMID: 20932595

3

Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.

Rowe IA, Tully DC, Armstrong MJ, Parker R, Guo K, Barton D, Morse GD, Venuto CS, Ogilvie CB, Hedegaard DL, McKelvy JF, Wong-Staal F, Allen TM, Balfe P, McKeating JA, Mutimer DJ. Rowe IA, et al. Among authors: mckelvy jf. Liver Transpl. 2016 Mar;22(3):287-97. doi: 10.1002/lt.24349. Liver Transpl. 2016. PMID: 26437376 Free PMC article. Clinical Trial.

4

Discovery of ITX 4520: a highly potent orally bioavailable hepatitis C virus entry inhibitor.

Mittapalli GK, Zhao F, Jackson A, Gao H, Lee H, Chow S, Kaur MP, Nguyen N, Zamboni R, McKelvy J, Wong-Staal F, Macdonald JE. Mittapalli GK, et al. Among authors: mckelvy j. Bioorg Med Chem Lett. 2012 Aug 1;22(15):4955-61. doi: 10.1016/j.bmcl.2012.06.038. Epub 2012 Jun 19. Bioorg Med Chem Lett. 2012. PMID: 22784640

5

Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.

Mittapalli GK, Jackson A, Zhao F, Lee H, Chow S, McKelvy J, Wong-Staal F, Macdonald JE. Mittapalli GK, et al. Among authors: mckelvy j. Bioorg Med Chem Lett. 2011 Nov 15;21(22):6852-5. doi: 10.1016/j.bmcl.2011.09.019. Epub 2011 Sep 16. Bioorg Med Chem Lett. 2011. PMID: 21978675

6

Targeting HCV entry for development of therapeutics.

Wong-Staal F, Syder AJ, McKelvy JF. Wong-Staal F, et al. Among authors: mckelvy jf. Viruses. 2010 Aug;2(8):1718-1733. doi: 10.3390/v2081718. Epub 2010 Aug 18. Viruses. 2010. PMID: 21994703 Free PMC article.

7

ITX 5061 quantitation in human plasma with reverse phase liquid chromatography and mass spectrometry detection.

Hochreiter J, Lapham J, Wong-Staal F, McKelvy J, Sulkowski M, Glesby MJ, Johnson VA, Morse GD. Hochreiter J, et al. Among authors: mckelvy j. Antivir Ther. 2013;18(3):329-36. doi: 10.3851/IMP2354. Epub 2012 Sep 6. Antivir Ther. 2013. PMID: 22954720

8

Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.

Li QX, Yu DH, Liu G, Ke N, McKelvy J, Wong-Staal F. Li QX, et al. Among authors: mckelvy j. Cell Death Differ. 2008 Aug;15(8):1197-210. doi: 10.1038/cdd.2008.48. Epub 2008 Apr 25. Cell Death Differ. 2008. PMID: 18437165 Review.

9

Advances in pain therapeutics.

LoGrasso P, McKelvy J. LoGrasso P, et al. Among authors: mckelvy j. Curr Opin Chem Biol. 2003 Aug;7(4):452-6. doi: 10.1016/s1367-5931(03)00078-4. Curr Opin Chem Biol. 2003. PMID: 12941418 Review.

10

The pipeline for antiepileptic drugs.

McKelvy JF. McKelvy JF. Epilepsy Res Suppl. 1993;10:3-8. Epilepsy Res Suppl. 1993. PMID: 8251104 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters